EFIS is a non-profit umbrella organisation that represents 36 European immunology societies. Via funding initiatives and awards, EFIS helps to support immunological research and education and strengthens scientific interaction via study groups, task forces and its triennial congress - the European Congress of Immunology (ECI).
EFIS is a non-profit umbrella organisation that represents 36 immunology societies in Europe. Via funding initiatives and awards, EFIS helps to support immunological research and education and strengthens scientific interaction via study groups, task forces and its triennial congress - the ECI.
11 Feb 2025
The Reaction to SARS-CoV-2: an Immunological Retrospective
The Reaction to SARS-CoV-2: an Immunological Retrospective
15 Feb 2025
2025 - 2027 EFIS Board
Congratulations are in order for the members of the newly elected EFIS Board!
14 Aug 2024
The 2024 EJI Ita Askonas Prize Awarded by EFIS
On the recommendation of its Gender & Diversity Task Force, EFIS is delighted to announce Dr. Sarina Ravens, Hannover Medical School, as the recipient of the 2024 EJI Ita Askonas Prize awarded by EFIS.
View all news
At the EFIS General Assembly held during the 2024 ECI in Dublin, the new EFIS Board was elected. Continue reading to learn more about them.
Find out more
11 Feb 2025
ISG15‐Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans
11 Feb 2025
Bystander Expression of Atypical Chemokine Receptor 2 Protects T Cells from Chemoattraction towards Cancer‐Associated Fibroblasts
11 Feb 2025
Deciphering the Human Germinal Center: A Review of Models to Study T–B Cell Interactions
30 Jan 2025
Striking the Right Chord at EJI: Introducing Editor‐in‐Chief Matteo Iannacone and the Seamless Transfer Policy
24 Jan 2025
The Anti‐Human P2X7 Monoclonal Antibody (Clone L4) Can Mediate Complement‐Dependent Cytotoxicity of Human Leukocytes
USP7 - A novel target for controlling periodontal inflammation through modulation of macrophage polarization
Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases
Systemic and cerebrospinal fluid immune mediators coordinate a dichotomic microenvironment in parturients with acute or convalescent phases of COVID-19
IL-21 promotes plasmablast differentiation independently of proliferation <em>in vitro</em>
Maternal immunoglobulins differentially bind a diverse bacterial community in human colostrum and the stool of breastfed neonates